Timetable

Wednesday, September 4, 2019

  Hall A (CME Track)  
 15:30 – 15:45 Congress opening
 15:45 – 17:30 Plenary Session 1:
Neoadjuvant therapy
17:30 – 19:00 Plenary Session 2:
Controversies in trials: Designs, endpoints, etc.
19:00 Networking Reception

 

Thursday, September 5, 2019

  Hall A (CME Track) Hall B (Non CME Track)
 06:45 – 08:00 Industry Breakfast Symposium
08:00 – 09:30 Plenary Session 3:
Genetics
09:30 – 10:30 Parallel Session 4:
Endocrine therapy side effects
Parallel Session 5:
Imaging/Screening
 10:30 – 11:00 Coffee break and poster viewing
11:00 – 12:30 Parallel Session 6:
Topics in HER2 positive breast cancer:
Adjuvant/neoadjuvant
Parallel Session 7:
DCIS
 12:30 – 14:00 Lunch Break and poster viewing
12:45 – 13:45 Industry Lunch Symposium
14:00 – 15:30 Plenary Session 8:
Imaging in systemic disease
15:30 – 16:00 Coffee break and poster viewing
16:00 – 17:00 Parallel Session 9:
Issues in loco-regional management
Parallel Session 10:
Free papers
17:00 – 18:00 Poster session
 

 

Friday, September 6, 2019

  Hall A (CME Track) Hall B (Non CME Track)
 06:45 – 08:00 Industry Breakfast Symposium
08:00 – 09:30 Parallel Session 11:
Adjuvant endocrine therapy
Parallel Session 12:
Imaging as locoregional staging
09:30 – 10:30 Parallel Session 13:
Triple negative breast cancer
Parallel Session 14:
Local therapy
10:30 – 11:00 Coffee break and poster viewing
11:00 – 12:30 Plenary Session 15:
Issues in advance disease
12:30 – 13:45 Lunch Break and Poster Viewing
12:45 – 13:45 Industry Lunch Symposium
13:45 – 15:15 Parallel Session 16
Reconstruction
Parallel Session 17:
Met HR+ve BC – CDK 4/6 inhibitors
15:15 – 16:15 Plenary Session 18:
Vision for breast cancer 2025
16:15 – 16:30 Congress closing and award presentation